A single high-affinity binding site for von Willebrand factor in collagen III, identified using synthetic triple-helical peptides

Blood

Volumn 108, Issue 12, 2006, Pages 3753-3756

  Lisman, Ton ^a   Raynal, Nicolas ^a   Groeneveld, Dafna ^a   Maddox, Ben ^a   Peachey, Anthony R ^a   Huizinga, Eric G ^a   De Groot, Philip G ^a   Farndale, Richard W ^a  

^a Department of Biochemistry ^*

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; ARGINYLGLYCYLGLUTAMINYLHYDROXYPROLINEGLYCYLVALYLMETHIONYLGLYCYLPHENYLALANYL; COLLAGEN TYPE 3; GLYCOPROTEIN IB ALPHA; GLYCOPROTEIN VI; PEPTIDE DERIVATIVE; VERY LATE ACTIVATION ANTIGEN 2; VON WILLEBRAND FACTOR;

AMINO ACID SEQUENCE; ARTICLE; BINDING AFFINITY; BINDING SITE; HUMAN; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN INTERACTION; THROMBOCYTE ADHESION; TRIPLE HELIX;

EID: 33845268866     PISSN: 00064971     EISSN: 00064971     Source Type: Journal    
DOI: 10.1182/blood-2006-03-011965     Document Type: Article

References (20)

1. Santoro SA. Preferential binding of high molecular weight forms of von Willebrand factor to fibrillar collagen. Biochim Biophys Acta. 1983;756:123-126.
2. Farndale RW, Sixma JJ, Barnes MJ, de Groot PG. Role of collagen in thrombosis and haemostasis. J Thromb Haemost. 2004;2:561-573.
3. Romijn RA, Bouma B, Wuyster W, et al. Identification of the collagen-binding site of the von Willebrand factor A3-domain. J Biol Chem. 2001;276:9985-9991.
4. Romijn RA, Westein E, Bouma B, et al. Mapping the collagen-binding site in the von Willebrand factor-A3 domain. J Biol Chem. 2003;278:15035-15039.
5. Nishida N, Sumikawa H, Sakakura M, et al. Collagen-binding mode of vWF-A3 domain determined by a transferred cross-saturation experiment. Nat Struct Biol. 2003;10:53-58.
6. Knight CG, Morton LF, Onley DJ, et al. Collagen-platelet interaction: Gly-Pro-Hyp is uniquely specific for platelet GpVI and mediates platelet activation by collagen. Cardiovasc Res. 1999;41:450-457.
7. Emsley J, Knight CG, Farndale RW, Barnes MJ, Liddington RC. Structural basis of collagen recognition by α2β1. Cell. 2000;101:47-56.
8. Raynal N, Hamaia SW, Siljander PR, et al. Use of synthetic peptides to locate novel integrin alpha2beta1-binding motifs in human collagen III. J Biol Chem. 2006;281:3821-3831.
9. Wu D, Vanhoorelbeke K, Cauwenberghs N, et al. Inhibition of the von Willebrand (VWF)-collagen interaction by an antihuman VWF monoclonal antibody results in abolition of in vivo arterial platelet thrombus formation in baboons. Blood. 2002;99:3623-3628.
10. Lasser G, Guchhait P, Ellsworth JL, et al. C1qTNF-related protein-1 (CTRP-1): a vascular wall protein that inhibits collagen-induced platelet aggregation by blocking VWF binding to collagen. Blood. 2006;107:423-430.
11. 2+-dependent binding of collagen by the integrin α2β1 in human platelets. J Biol Chem. 2000;275:24560-24566.
12. van der Plas RM, Gomes L, Marquart JA, et al. Binding of von Willebrand factor to collagen type III: role of specific amino acids in the collagen binding domain of vWF and effects of neighboring domains. Thromb Haemost. 2000;84:1005-1011.
13. Sixma JJ, de Groot PG, van Zanten H, Ijsseldijk M. A new perfusion chamber to detect platelet adhesion using a small volume of blood. Thromb Res. 1998;92:S43-S46.
14. Lisman T, Moschatsis S, Adelmeijer J, Nieuwenhuis HK, De Groot PG. Recombinant factor VIIa enhances deposition of platelets with congenital or acquired alpha IIb beta 3 deficiency to endothelial cell matrix and collagen under conditions of flow via tissue factor-independent thrombin generation. Blood. 2003;101:1864-1870.
15. Lankhof H, van Hoeij M, Schiphorst ME, et al. A3 domain is essential for interaction of von Willebrand factor with collagen type III. Thromb Haemost. 1996;75:950-958.
16. Huizinga EG, van der Plas RM, Kroon J, Sixma JJ, Gros P. Crystal structure of the A3 domain of human von Willebrand factor: implications for collagen binding. Structure. 1997;5:1147-1156.
17. Cruz MA, Yuan H, Lee JR, Wise RJ, Handin RI. Interaction of the von Willebrand factor (vWF) with collagen: localization of the primary collagen-binding site by analysis of recombinant vWF a domain polypeptides. J Biol Chem. 1995;270:10822-10827.
18. Verkleij MW, Ijsseldijk MJW, Heijnen-Snyder GJ, et al. Adhesive domains in the collagen III fragment α1(III)CB4 that support α2β1- and von Willebrand factor-mediated platelet adhesion under flow conditions. Thromb Haemost. 1999;82:1137-1144.
19. Morales LD, Martin C, Cruz MA. The interaction of von Willebrand factor-A1 domain with collagen: mutation G1324S (type 2M von Willebrand disease) impairs the conformational change in A1 domain induced by collagen. J Thromb Haemost. 2006;4:417-425.
20. Ahrens I, Bode C, Peter K. Inhibition of platelet activation and aggregation. Handb Exp Pharmacol. 2005;170:443-462.